APO Research
Talk to an analyst

APO RESEARCH · REPORT

α4β7 Integrin Antagonists

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global α4β7 Integrin Antagonists Industry Growth and Trends Forecast to 2032

28 December 202574 pages

Choose your research edition.

Industry Researchα4β7 Integrin Antagonists Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal α4β7 Integrin Antagonists Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal α4β7 Integrin Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal α4β7 Integrin Antagonists Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal α4β7 Integrin Antagonists Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global α4β7 Integrin Antagonists market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for α4β7 Integrin Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for α4β7 Integrin Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for α4β7 Integrin Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of α4β7 Integrin Antagonists include Biogen, Novartis, Sandoz and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global α4β7 Integrin Antagonists market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The α4β7 Integrin Antagonists market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global α4β7 Integrin Antagonists market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to α4β7 Integrin Antagonists.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global α4β7 Integrin Antagonists market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

α4β7 Integrin Antagonists Market by Company

Biogen

Novartis

Sandoz

Takeda

α4β7 Integrin Antagonists Segment by Type

Natalizumub

Vedolizumab

α4β7 Integrin Antagonists Segment by Application

Inflammatory Bowel Disease (IBD)

Multiple Sclerosis (MS)

Other

α4β7 Integrin Antagonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global α4β7 Integrin Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of α4β7 Integrin Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of α4β7 Integrin Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of α4β7 Integrin Antagonists manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of α4β7 Integrin Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Natalizumub Table 2. Major Company of Vedolizumab Table 3. Global α4β7 Integrin Antagonists Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global α4β7 Integrin Antagonists Sales by Type (2021-2026) & (K Units) Table 5. Global α4β7 Integrin Antagonists Sales Market Share in Volume by Type (2021-2026) Table 6. Global α4β7 Integrin Antagonists Sales by Type (2021-2026) & (US$ Million) Table 7. Global α4β7 Integrin Antagonists Sales Market Share in Value by Type (2021-2026) Table 8. Global α4β7 Integrin Antagonists Price by Type (2021-2026) & (US$/Unit) Table 9. Global α4β7 Integrin Antagonists Sales by Type (2027-2032) & (K Units) Table 10. Global α4β7 Integrin Antagonists Sales Market Share in Volume by Type (2027-2032) Table 11. Global α4β7 Integrin Antagonists Sales by Type (2027-2032) & (US$ Million) Table 12. Global α4β7 Integrin Antagonists Sales Market Share in Value by Type (2027-2032) Table 13. Global α4β7 Integrin Antagonists Price by Type (2027-2032) & (US$/Unit) Table 14. North America α4β7 Integrin Antagonists Sales by Type (2021-2026) & (K Units) Table 15. North America α4β7 Integrin Antagonists Sales by Type (2021-2026) & (US$ Million) Table 16. Europe α4β7 Integrin Antagonists Sales by Type (2021-2026) & (K Units) Table 17. Europe α4β7 Integrin Antagonists Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific α4β7 Integrin Antagonists Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific α4β7 Integrin Antagonists Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America α4β7 Integrin Antagonists Sales by Type (2021-2026) & (K Units) Table 21. Latin America α4β7 Integrin Antagonists Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa α4β7 Integrin Antagonists Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa α4β7 Integrin Antagonists Sales by Type (2021-2026) & (US$ Million) Table 24. α4β7 Integrin Antagonists Industry Trends Table 25. α4β7 Integrin Antagonists Industry Drivers Table 26. α4β7 Integrin Antagonists Industry Opportunities and Challenges Table 27. α4β7 Integrin Antagonists Industry Restraints Table 28. Global α4β7 Integrin Antagonists Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global α4β7 Integrin Antagonists Revenue Market Share by Company (2021-2026) Table 30. Global α4β7 Integrin Antagonists Sales by Company (2021-2026) & (K Units) Table 31. Global α4β7 Integrin Antagonists Sales Share by Company (2021-2026) Table 32. Global α4β7 Integrin Antagonists Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global α4β7 Integrin Antagonists Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global α4β7 Integrin Antagonists Major Company Production Sites and Headquarters Table 35. Global α4β7 Integrin Antagonists Company, Product Type & Application Table 36. Global α4β7 Integrin Antagonists Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global α4β7 Integrin Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global α4β7 Integrin Antagonists Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global α4β7 Integrin Antagonists Sales by Region (2021-2026) & (K Units) Table 41. Global α4β7 Integrin Antagonists Sales Market Share in Volume by Region (2021-2026) Table 42. Global α4β7 Integrin Antagonists Sales by Region (2021-2026) & (US$ Million) Table 43. Global α4β7 Integrin Antagonists Sales Market Share in Value by Region (2021-2026) Table 44. Global α4β7 Integrin Antagonists Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global α4β7 Integrin Antagonists Sales by Region (2027-2032) & (K Units) Table 46. Global α4β7 Integrin Antagonists Sales Market Share in Volume by Region (2027-2032) Table 47. Global α4β7 Integrin Antagonists Sales by Region (2027-2032) & (US$ Million) Table 48. Global α4β7 Integrin Antagonists Sales Market Share in Value by Region (2027-2032) Table 49. Global α4β7 Integrin Antagonists Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global α4β7 Integrin Antagonists Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global α4β7 Integrin Antagonists Sales by Application (2021-2026) & (K Units) Table 52. Global α4β7 Integrin Antagonists Sales Market Share in Volume by Application (2021-2026) Table 53. Global α4β7 Integrin Antagonists Sales by Application (2021-2026) & (US$ Million) Table 54. Global α4β7 Integrin Antagonists Sales Market Share in Value by Application (2021-2026) Table 55. Global α4β7 Integrin Antagonists Price by Application (2021-2026) & (US$/Unit) Table 56. Global α4β7 Integrin Antagonists Sales by Application (2027-2032) & (K Units) Table 57. Global α4β7 Integrin Antagonists Sales Market Share in Volume by Application (2027-2032) Table 58. Global α4β7 Integrin Antagonists Sales by Application (2027-2032) & (US$ Million) Table 59. Global α4β7 Integrin Antagonists Sales Market Share in Value by Application (2027-2032) Table 60. Global α4β7 Integrin Antagonists Price by Application (2027-2032) & (US$/Unit) Table 61. North America α4β7 Integrin Antagonists Sales by Application (2021-2026) & (K Units) Table 62. North America α4β7 Integrin Antagonists Sales by Application (2021-2026) & (US$ Million) Table 63. Europe α4β7 Integrin Antagonists Sales by Application (2021-2026) & (K Units) Table 64. Europe α4β7 Integrin Antagonists Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific α4β7 Integrin Antagonists Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific α4β7 Integrin Antagonists Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America α4β7 Integrin Antagonists Sales by Application (2021-2026) & (K Units) Table 68. Latin America α4β7 Integrin Antagonists Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa α4β7 Integrin Antagonists Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa α4β7 Integrin Antagonists Sales by Application (2021-2026) & (US$ Million) Table 71. Biogen Company Information Table 72. Biogen Business Overview Table 73. Biogen α4β7 Integrin Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Biogen α4β7 Integrin Antagonists Product Portfolio Table 75. Biogen Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis α4β7 Integrin Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Novartis α4β7 Integrin Antagonists Product Portfolio Table 80. Novartis Recent Development Table 81. Sandoz Company Information Table 82. Sandoz Business Overview Table 83. Sandoz α4β7 Integrin Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sandoz α4β7 Integrin Antagonists Product Portfolio Table 85. Sandoz Recent Development Table 86. Takeda Company Information Table 87. Takeda Business Overview Table 88. Takeda α4β7 Integrin Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Takeda α4β7 Integrin Antagonists Product Portfolio Table 90. Takeda Recent Development Table 91. North America α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America α4β7 Integrin Antagonists Sales by Country (2021-2026) & (K Units) Table 93. North America α4β7 Integrin Antagonists Sales Market Share by Country (2021-2026) Table 94. North America α4β7 Integrin Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America α4β7 Integrin Antagonists Sales Market Share Forecast by Country (2027-2032) Table 96. North America α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America α4β7 Integrin Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 98. North America α4β7 Integrin Antagonists Market Share by Country (2021-2026) Table 99. North America α4β7 Integrin Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America α4β7 Integrin Antagonists Market Share Forecast by Country (2027-2032) Table 101. Europe α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe α4β7 Integrin Antagonists Sales by Country (2021-2026) & (K Units) Table 103. Europe α4β7 Integrin Antagonists Sales Market Share by Country (2021-2026) Table 104. Europe α4β7 Integrin Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe α4β7 Integrin Antagonists Sales Market Share Forecast by Country (2027-2032) Table 106. Europe α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe α4β7 Integrin Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe α4β7 Integrin Antagonists Market Share by Country (2021-2026) Table 109. Europe α4β7 Integrin Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe α4β7 Integrin Antagonists Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific α4β7 Integrin Antagonists Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific α4β7 Integrin Antagonists Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific α4β7 Integrin Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific α4β7 Integrin Antagonists Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific α4β7 Integrin Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific α4β7 Integrin Antagonists Market Share by Country (2021-2026) Table 119. Asia-Pacific α4β7 Integrin Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific α4β7 Integrin Antagonists Market Share Forecast by Country (2027-2032) Table 121. Latin America α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America α4β7 Integrin Antagonists Sales by Country (2021-2026) & (K Units) Table 123. Latin America α4β7 Integrin Antagonists Sales Market Share by Country (2021-2026) Table 124. Latin America α4β7 Integrin Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America α4β7 Integrin Antagonists Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America α4β7 Integrin Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America α4β7 Integrin Antagonists Market Share by Country (2021-2026) Table 129. Latin America α4β7 Integrin Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America α4β7 Integrin Antagonists Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa α4β7 Integrin Antagonists Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa α4β7 Integrin Antagonists Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa α4β7 Integrin Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa α4β7 Integrin Antagonists Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa α4β7 Integrin Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa α4β7 Integrin Antagonists Market Share by Country (2021-2026) Table 139. Middle East and Africa α4β7 Integrin Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa α4β7 Integrin Antagonists Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. α4β7 Integrin Antagonists Distributors List Table 144. α4β7 Integrin Antagonists Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. α4β7 Integrin Antagonists Image Figure 2. Global α4β7 Integrin Antagonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global α4β7 Integrin Antagonists Market Size (2021-2032) & (US$ Million) Figure 4. Global α4β7 Integrin Antagonists Sales (2021-2032) & (K Units) Figure 5. Natalizumub Image Figure 6. Global Natalizumub Sales YoY Growth (2021-2032) & (K Units) Figure 7. Vedolizumab Image Figure 8. Global Vedolizumab Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global α4β7 Integrin Antagonists Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global α4β7 Integrin Antagonists Market Share by Type 2025 VS 2032 Figure 11. North America α4β7 Integrin Antagonists Sales Market Share in Volume by Type in 2025 Figure 12. North America α4β7 Integrin Antagonists Sales Market Share in Value by Type in 2025 Figure 13. Europe α4β7 Integrin Antagonists Sales Market Share in Volume by Type in 2025 Figure 14. Europe α4β7 Integrin Antagonists Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific α4β7 Integrin Antagonists Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific α4β7 Integrin Antagonists Sales Market Share in Value by Type in 2025 Figure 17. Latin America α4β7 Integrin Antagonists Sales Market Share in Volume by Type in 2025 Figure 18. Latin America α4β7 Integrin Antagonists Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa α4β7 Integrin Antagonists Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa α4β7 Integrin Antagonists Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 α4β7 Integrin Antagonists Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Inflammatory Bowel Disease (IBD) Image Figure 24. Global Inflammatory Bowel Disease (IBD) Sales YoY Growth (2021-2032) & (K Units) Figure 25. Multiple Sclerosis (MS) Image Figure 26. Global Multiple Sclerosis (MS) Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global α4β7 Integrin Antagonists Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global α4β7 Integrin Antagonists Market Share by Application 2025 VS 2032 Figure 31. North America α4β7 Integrin Antagonists Sales Market Share in Volume by Application in 2025 Figure 32. North America α4β7 Integrin Antagonists Sales Market Share in Value by Application in 2025 Figure 33. Europe α4β7 Integrin Antagonists Sales Market Share in Volume by Application in 2025 Figure 34. Europe α4β7 Integrin Antagonists Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific α4β7 Integrin Antagonists Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific α4β7 Integrin Antagonists Sales Market Share in Value by Application in 2025 Figure 37. Latin America α4β7 Integrin Antagonists Sales Market Share in Volume by Application in 2025 Figure 38. Latin America α4β7 Integrin Antagonists Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa α4β7 Integrin Antagonists Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa α4β7 Integrin Antagonists Sales Market Share in Value by Application in 2025 Figure 41. North America α4β7 Integrin Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America α4β7 Integrin Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America α4β7 Integrin Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America α4β7 Integrin Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe α4β7 Integrin Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe α4β7 Integrin Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe α4β7 Integrin Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe α4β7 Integrin Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific α4β7 Integrin Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific α4β7 Integrin Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific α4β7 Integrin Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific α4β7 Integrin Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America α4β7 Integrin Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America α4β7 Integrin Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America α4β7 Integrin Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America α4β7 Integrin Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa α4β7 Integrin Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa α4β7 Integrin Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa α4β7 Integrin Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa α4β7 Integrin Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. α4β7 Integrin Antagonists Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. α4β7 Integrin Antagonists Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Natalizumub
  • Vedolizumab
Applications
  • Inflammatory Bowel Disease (IBD)
  • Multiple Sclerosis (MS)
  • Other
Companies covered
  • Biogen
  • Novartis
  • Sandoz
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global α4β7 Integrin Antagonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global α4β7 Integrin Antagonists Sales Estimates and Forecasts (2021-2032)
  5. 1.3 α4β7 Integrin Antagonists Market by Type
  6. 1.3.1 Natalizumub
  7. 1.3.2 Vedolizumab
  8. 1.4 Global α4β7 Integrin Antagonists Market Size by Type
  9. 1.4.1 Global α4β7 Integrin Antagonists Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global α4β7 Integrin Antagonists Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global α4β7 Integrin Antagonists Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America α4β7 Integrin Antagonists Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe α4β7 Integrin Antagonists Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific α4β7 Integrin Antagonists Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America α4β7 Integrin Antagonists Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa α4β7 Integrin Antagonists Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 α4β7 Integrin Antagonists Industry Trends
  2. 2.2 α4β7 Integrin Antagonists Industry Drivers
  3. 2.3 α4β7 Integrin Antagonists Industry Opportunities and Challenges
  4. 2.4 α4β7 Integrin Antagonists Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by α4β7 Integrin Antagonists Revenue (2021-2026)
  2. 3.2 Global Top Players by α4β7 Integrin Antagonists Sales (2021-2026)
  3. 3.3 Global Top Players by α4β7 Integrin Antagonists Price (2021-2026)
  4. 3.4 Global α4β7 Integrin Antagonists Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global α4β7 Integrin Antagonists Major Company Production Sites & Headquarters
  6. 3.6 Global α4β7 Integrin Antagonists Company, Product Type & Application
  7. 3.7 Global α4β7 Integrin Antagonists Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global α4β7 Integrin Antagonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 α4β7 Integrin Antagonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 α4β7 Integrin Antagonists Tier 1, Tier 2, and Tier 3
4 α4β7 Integrin Antagonists Regional Status and Outlook
  1. 4.1 Global α4β7 Integrin Antagonists Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global α4β7 Integrin Antagonists Historic Market Size by Region
  3. 4.2.1 Global α4β7 Integrin Antagonists Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global α4β7 Integrin Antagonists Sales in Value by Region (2021-2026)
  5. 4.2.3 Global α4β7 Integrin Antagonists Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global α4β7 Integrin Antagonists Forecasted Market Size by Region
  7. 4.3.1 Global α4β7 Integrin Antagonists Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global α4β7 Integrin Antagonists Sales in Value by Region (2027-2032)
  9. 4.3.3 Global α4β7 Integrin Antagonists Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 α4β7 Integrin Antagonists by Application
  1. 5.1 α4β7 Integrin Antagonists Market by Application
  2. 5.1.1 Inflammatory Bowel Disease (IBD)
  3. 5.1.2 Multiple Sclerosis (MS)
  4. 5.1.3 Other
  5. 5.2 Global α4β7 Integrin Antagonists Market Size by Application
  6. 5.2.1 Global α4β7 Integrin Antagonists Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global α4β7 Integrin Antagonists Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global α4β7 Integrin Antagonists Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America α4β7 Integrin Antagonists Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe α4β7 Integrin Antagonists Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific α4β7 Integrin Antagonists Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America α4β7 Integrin Antagonists Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa α4β7 Integrin Antagonists Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biogen
  2. 6.1.1 Biogen Company Information
  3. 6.1.2 Biogen Business Overview
  4. 6.1.3 Biogen α4β7 Integrin Antagonists Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biogen α4β7 Integrin Antagonists Product Portfolio
  6. 6.1.5 Biogen Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis α4β7 Integrin Antagonists Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis α4β7 Integrin Antagonists Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Sandoz
  14. 6.3.1 Sandoz Company Information
  15. 6.3.2 Sandoz Business Overview
  16. 6.3.3 Sandoz α4β7 Integrin Antagonists Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sandoz α4β7 Integrin Antagonists Product Portfolio
  18. 6.3.5 Sandoz Recent Developments
  19. 6.4 Takeda
  20. 6.4.1 Takeda Company Information
  21. 6.4.2 Takeda Business Overview
  22. 6.4.3 Takeda α4β7 Integrin Antagonists Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Takeda α4β7 Integrin Antagonists Product Portfolio
  24. 6.4.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America α4β7 Integrin Antagonists Sales by Country
  2. 7.1.1 North America α4β7 Integrin Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America α4β7 Integrin Antagonists Sales by Country (2021-2026)
  4. 7.1.3 North America α4β7 Integrin Antagonists Sales Forecast by Country (2027-2032)
  5. 7.2 North America α4β7 Integrin Antagonists Market Size by Country
  6. 7.2.1 North America α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America α4β7 Integrin Antagonists Market Size by Country (2021-2026)
  8. 7.2.3 North America α4β7 Integrin Antagonists Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe α4β7 Integrin Antagonists Sales by Country
  2. 8.1.1 Europe α4β7 Integrin Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe α4β7 Integrin Antagonists Sales by Country (2021-2026)
  4. 8.1.3 Europe α4β7 Integrin Antagonists Sales Forecast by Country (2027-2032)
  5. 8.2 Europe α4β7 Integrin Antagonists Market Size by Country
  6. 8.2.1 Europe α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe α4β7 Integrin Antagonists Market Size by Country (2021-2026)
  8. 8.2.3 Europe α4β7 Integrin Antagonists Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific α4β7 Integrin Antagonists Sales by Country
  2. 9.1.1 Asia-Pacific α4β7 Integrin Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific α4β7 Integrin Antagonists Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific α4β7 Integrin Antagonists Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific α4β7 Integrin Antagonists Market Size by Country
  6. 9.2.1 Asia-Pacific α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific α4β7 Integrin Antagonists Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific α4β7 Integrin Antagonists Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America α4β7 Integrin Antagonists Sales by Country
  2. 10.1.1 South America α4β7 Integrin Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America α4β7 Integrin Antagonists Sales by Country (2021-2026)
  4. 10.1.3 South America α4β7 Integrin Antagonists Sales Forecast by Country (2027-2032)
  5. 10.2 South America α4β7 Integrin Antagonists Market Size by Country
  6. 10.2.1 South America α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America α4β7 Integrin Antagonists Market Size by Country (2021-2026)
  8. 10.2.3 South America α4β7 Integrin Antagonists Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa α4β7 Integrin Antagonists Sales by Country
  2. 11.1.1 Middle East and Africa α4β7 Integrin Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa α4β7 Integrin Antagonists Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa α4β7 Integrin Antagonists Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa α4β7 Integrin Antagonists Market Size by Country
  6. 11.2.1 Middle East and Africa α4β7 Integrin Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa α4β7 Integrin Antagonists Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa α4β7 Integrin Antagonists Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 α4β7 Integrin Antagonists Value Chain Analysis
  2. 12.1.1 α4β7 Integrin Antagonists Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 α4β7 Integrin Antagonists Production Mode & Process
  7. 12.2 α4β7 Integrin Antagonists Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 α4β7 Integrin Antagonists Distributors
  10. 12.2.3 α4β7 Integrin Antagonists Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst